130 related articles for article (PubMed ID: 31026162)
1. Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin.
Li Y; He Y; Shao T; Pei H; Guo W; Mi D; Krimm I; Zhang Y; Wang P; Wang X; Liu M; Yi Z; Chen Y
J Med Chem; 2019 May; 62(10):4949-4966. PubMed ID: 31026162
[TBL] [Abstract][Full Text] [Related]
2. A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer.
Zhang T; Li J; He Y; Yang F; Hao Y; Jin W; Wu J; Sun Z; Li Y; Chen Y; Yi Z; Liu M
Nat Commun; 2018 Sep; 9(1):3726. PubMed ID: 30213946
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer.
Gu H; Zhang T; Li Y; He Y; Guan T; Kan W; He P; Yi Z; Chen Y
Future Med Chem; 2022 Oct; 14(20):1425-1440. PubMed ID: 36165130
[No Abstract] [Full Text] [Related]
4. An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors.
Gu H; Peng Y; Chen Y
Curr Top Med Chem; 2020; 20(17):1509-1515. PubMed ID: 32552653
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.
Gu H; Zhang T; Guan T; Wu M; Li S; Li Y; Guo M; Zhang L; Peng Y; Mi D; Liu M; Yi Z; Chen Y
J Med Chem; 2023 Dec; 66(24):16917-16938. PubMed ID: 38054798
[TBL] [Abstract][Full Text] [Related]
6. A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression.
He Y; Kan W; Li Y; Hao Y; Huang A; Gu H; Wang M; Wang Q; Chen J; Sun Z; Liu M; Chen Y; Yi Z
Clin Transl Med; 2021 Feb; 11(2):e289. PubMed ID: 33634965
[TBL] [Abstract][Full Text] [Related]
7. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
Razidlo GL; Magnine C; Sletten AC; Hurley RM; Almada LL; Fernandez-Zapico ME; Ji B; McNiven MA
Cancer Res; 2015 Jul; 75(14):2907-15. PubMed ID: 25977335
[TBL] [Abstract][Full Text] [Related]
8. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase.
Park JM; Han YM; Jeong M; Chung MH; Kwon CI; Ko KH; Hahm KB
Free Radic Biol Med; 2017 Sep; 110():151-161. PubMed ID: 28602912
[TBL] [Abstract][Full Text] [Related]
9. Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo.
Komachi M; Sato K; Tobo M; Mogi C; Yamada T; Ohta H; Tomura H; Kimura T; Im DS; Yanagida K; Ishii S; Takeyoshi I; Okajima F
Cancer Sci; 2012 Jun; 103(6):1099-104. PubMed ID: 22348348
[TBL] [Abstract][Full Text] [Related]
10. Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway.
Subramani R; Gonzalez E; Nandy SB; Arumugam A; Camacho F; Medel J; Alabi D; Lakshmanaswamy R
Oncotarget; 2017 Feb; 8(7):10891-10904. PubMed ID: 26988754
[TBL] [Abstract][Full Text] [Related]
11. ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.
Yuan L; Zhao J; Zhao S; Dong T; Dong R; Liu D; Ma E; Li Y
Chem Biol Interact; 2022 Feb; 353():109811. PubMed ID: 35016848
[TBL] [Abstract][Full Text] [Related]
12. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.
Rumman M; Jung KH; Fang Z; Yan HH; Son MK; Kim SJ; Kim J; Park JH; Lim JH; Hong S; Hong SS
Oncotarget; 2016 Nov; 7(47):78029-78047. PubMed ID: 27793006
[TBL] [Abstract][Full Text] [Related]
13. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer.
Zong L; Chen K; Jiang Z; Chen X; Sun L; Ma J; Zhou C; Xu Q; Duan W; Han L; Lei J; Li X; Ma Q; Wang Z
J Exp Clin Cancer Res; 2017 Dec; 36(1):181. PubMed ID: 29228980
[TBL] [Abstract][Full Text] [Related]
14. Myoferlin is a key regulator of EGFR activity in breast cancer.
Turtoi A; Blomme A; Bellahcène A; Gilles C; Hennequière V; Peixoto P; Bianchi E; Noel A; De Pauw E; Lifrange E; Delvenne P; Castronovo V
Cancer Res; 2013 Sep; 73(17):5438-48. PubMed ID: 23864327
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.
Nagaoka K; Bai X; Ogawa K; Dong X; Zhang S; Zhou Y; Carlson RI; Jiang ZG; Fuller S; Lebowitz MS; Ghanbari H; Wands JR
Cancer Lett; 2019 May; 449():87-98. PubMed ID: 30768955
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors.
Guo S; Zhen Y; Guo M; Zhang L; Zhou G
Invest New Drugs; 2018 Dec; 36(6):1147-1157. PubMed ID: 30019099
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
19. Rubus idaeus L Inhibits Invasion Potential of Human A549 Lung Cancer Cells by Suppression Epithelial-to-Mesenchymal Transition and Akt Pathway In Vitro and Reduces Tumor Growth In Vivo.
Chu SC; Hsieh YS; Hsu LS; Chen KS; Chiang CC; Chen PN
Integr Cancer Ther; 2014 May; 13(3):259-73. PubMed ID: 24335666
[TBL] [Abstract][Full Text] [Related]
20. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
